相关实验视频

Updated: Jul 13, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

临床试验与质母细胞瘤生存相关联

Alexander L Ling¹, Isaac H Solomon^2,3, Ana Montalvo Landivar¹

¹Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA.

|October 18, 2023

概括

这一第一阶段试验表明,将瘤性疹病毒 (oHSV) CAN-3110注入复发性质母细胞瘤 (rGBM) 是安全的. 阳性HSV1血清患者的生存率提高,抗瘤免疫反应得到加强.

科学领域:

癌症学
病毒学
免疫学

背景情况:

像复发性质母细胞瘤 (rGBM) 这样的侵袭性癌症通常具有抑制性瘤微环境,限制了免疫治疗的有效性.
瘤病毒 (oV) 通过选择性向和破坏癌细胞,同时刺激抗瘤免疫反应,为克服这些挑战提供了一个潜在的策略.

研究的目的:

评估新型瘤性简单性疹病毒 (oHSV) CAN-3110 的安全性和初步疗效,用于复发性质母细胞瘤 (rGBM) 的患者.
在rGBM中探索对CAN-3110治疗反应的免疫学和病毒学相关性.

主要方法:

这是一项首次在人身上进行的I期临床试验,涉及41名RGBM患者,他们接受了CAN-3110的内伤注射.
安全性评估,包括剂量限制性毒性,以及病毒清除,瘤微环境变化,T细胞反应和瘤转录组的评估.
患者的HSV1血清状态与临床结果和免疫反应的相关性.

主要成果:

CAN-3110的使用耐受性很好,没有观察到剂量限制的毒性.
阳性HSV1血清与改善患者的生存率和有效清除注射瘤的CAN-3110相关.
治疗导致增强的抗瘤免疫反应,包括增加T细胞数量,克隆多样性和瘤中的免疫激活特征,特别是在HSV1阳性个体中.

结论:

即使在rGBM的免疫抑制微环境中,使用CAN-3110进行内治疗也显示出安全性和增强抗癌免疫反应的潜力.
这些发现为oHSV作为一种治疗方式提供了人类验证,并表明先前存在的HSV1免疫力可能会提高治疗效果,支持其在耐火性癌症中使用.

更多相关视频

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...